Evaluation of Dickkopf-3 in acute kidney injury in patients undergoing coronary angiography: A pilot atudy

  • Zeki Toprak Department of Nephrology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
  • Güngör İ. Bostancı Department of Cardiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
  • Yüksel G. Çiçek Department of Biochemistry, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
  • İbrahim F. Aktürk Department of Cardiology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
  • İlkim D. Toprak Department of Internal Medicine, Gaziosmanpasa Training and Research Hospital, Turkey
  • Egemen Cebeci Department of Nephrology, Haseki Training and Research Hospital, Istanbul, Turkey
  • Emre Akar Department of Internal Medicine, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
  • Mürvet Yılmaz Department of Nephrology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
  • Süheyla Apaydın Department of Nephrology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
Keywords: dickkopf-3, acute kidney injury, contrast-induced nephropathy, biomarkers

Abstract

Introduction: Urinary dickkopf-3 (DKK3), which is a kidney tubular stress marker has been suggested recently for preoperative identification of patients at risk of acute kidney injury. We aimed to assess the predictive role of urinary DKK3/creatinine (Cr) ratio in contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary intervention (PCI). Methods: This prospective observational study included patients undergoing elective PCI. The association between the ratio of precontrast urinary concentrations of DKK3/Cr and post contrast CIN. The serum Cr, urinary DKK3 and Cr levels of the patients were measured before and after contrast media administration, and the sensitivity of urinary DKK3/Cr ratio in diagnosing CIN in the early stage was assessed by the area under receiver operating characteristic curve. Results: A total of 44 patients (33 males) undergoing PCI were enrolled and mean age of the patients was 61.5 ± 10.0 years. 22.7% of the patients developed CIN, none of them received hemodialysis during hospitalization. The mean urinary DKK3/Cr ratio was 950 ± 491 pg/mg in the CIN patients versus 386 ± 272 pg/mg in the non- CIN patients before contrast media administration (p=0.001). The mean urinary DKK3/Cr ratio was 1266 ± 738 pg/mg in the CIN patients versus 305 ± 192 pg/mg in the non- CIN patients at 12th hour after contrast media infusion (p<0.001). The roc-curve for the urinary DKK3/Cr ratio before contrast administration (AUC=0.835, p=0.001). Conclusions: Pre-contrast urinary DKK3/Cr ratio is a predictor for CIN. Urinary DKK3/Cr ratio may help in the identification of patients who are at risk of CIN.

References

1) McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51(15):1419-28. doi: 10.1016/j.jacc.2007.12.035.

2) Rudnick MR, Goldfarb S. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. Rev Cardiovasc Med. 2003;4(Suppl. 5):S28-33.

3) Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005 Jul;68(1):14-22. doi: 10.1111/j.1523-1755.2005.00377.x.

4) Haller C, Hizoh I. The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest Radiol. 2004;39(3):149-54. doi: 10.1097/01.rli.0000113776.87762.49.

5) Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1-138.

6) Federico G, Meister M, Mathow D, Heine GH, Moldenhauer G, Popovic ZV, et al. Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis. JCI Insight. 2016;1(1):e84916. doi: 10.1172/jci.insight.84916.

7) Schunk SJ, Zarbock A, Meersch M, Küllmar M, Kellum JA, Schmit D, et al. Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study. Lancet. 2019;394(10197):488-96. doi: 10.1016/S0140-6736(19)30769-X.

8) Zewinger S, Rauen T, Rudnicki M, Federico G, Wagner M, Triem S, et al. Dickkopf-3 (DKK3) in urine identifies patients with short-term risk of eGFR loss. J Am Soc Nephrol. 2018;29(11):2722-33. doi: 10.1681/ASN.2018040405.

9) Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365-70. doi: 10.1681/ASN.2004090740.

10) Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol. 2001;12(1):3-9. doi: 10.1016/s1051-0443(07)61394-3.

11) Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989;320(3):143-9. doi: 10.1056/NEJM198901193200303.

12) Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19):2259-64. doi: 10.1161/01.cir.0000016043.87291.33.

13) Rudnick MR, Davidson C, Laskey W, Stafford JL, Sherwin PF; VALOR Trial Investigators. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial. Am Heart J. 2008;156(4):776-82. doi: 10.1016/j.ahj.2008.05.023.

14) Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ; Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348(6):491-9. doi: 10.1056/NEJMoa021833.

15) Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TN, et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med. 1989;320(3):149-53. doi: 10.1056/NEJM198901193200304.

16) Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med. 1990;150(6):1237-42.

17) Sánchez Álamo B, Corona CMC, García Iñigo FJ, Domínguez Torres P, Shabaka Fernández A, Ocaña J, et al. Urinary Dickkopf-3 (Dkk3) as a predictive factor for renal survival in established diabetic nephropathy. Nephrol Dial Transplant. 2019;34(Suppl. 1):207-8. doi: 10.1093/ndt/gfz106.FP489.

18) Seibert FS, Heringhaus A, Pagonas N, Rohn B, Bauer F, Trappe HJ, et al. Dickkopf-3 in the prediction of contrast media induced acute kidney injury. J Nephrol. 2021;34(3):821-8. doi: 10.1007/s40620-020-00910-1.

19) Piek A, Suthahar N, Voors AA, de Boer RA, Silljé HHW. A combined bioinformatics, experimental and clinical approach to identify novel cardiac-specific heart failure biomarkers: is Dickkopf-3 (DKK3) a possible candidate? Eur J Heart Fail. 2020;22(11):2065-74. doi: 10.1002/ejhf.1988.

20) Faucon AL, Bobrie G, Clément O. Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategies. Eur J Radiol. 2019;116:231-41. doi: 10.1016/j.ejrad.2019.03.008.

21) van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin MF, Bertolotto M, et al. Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2018;28(7):2845-55. doi: 10.1007/s00330-017-5246-5.
Published
2022-06-14
How to Cite
1.
Toprak Z, Güngör İ. Bostancı, Çiçek YG, Aktürk İbrahim F, Toprak İlkim D, Cebeci E, Akar E, Yılmaz M, Apaydın S. Evaluation of Dickkopf-3 in acute kidney injury in patients undergoing coronary angiography: A pilot atudy. Rev Nefrol Dial Traspl. [Internet]. 2022Jun.14 [cited 2024Sep.1];42(2):109-16. Available from: http://revistarenal.org.ar/index.php/rndt/article/view/788
Section
Original Article